APC-Cyanine7 Anti-Human CD11a (TS2/4) Mouse IgG2a Recombinant Antibody
CD11a Uni-rAbTM Recombinant Antibody for FC
Host / Isotype
Mouse / IgG2a
Reactivity
Human
Applications
FC
Conjugate
APC-Cyanine7 Fluorescent Dye
CloneNo.
TS2/4
Cat no : AY7-65563
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | human PBMCs |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 µl per 10^6 cells in a 100 µl suspension or 5 µl per 100 µl of whole blood. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
AY7-65563 targets CD11a in FC applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG2a |
Class | Recombinant |
Type | Antibody |
Immunogen | HLA-DR CTL line |
Full Name | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
Calculated Molecular Weight | 129 kDa |
GenBank Accession Number | BC008777 |
Gene Symbol | CD11a |
Gene ID (NCBI) | 3683 |
Conjugate | APC-Cyanine7 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 650 nm / 778 nm |
Form | Liquid |
Purification Method | Protein A purification |
Storage Buffer | PBS with 0.09% sodium azide and 0.5% BSA. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Background Information
CD11a, also known as integrin αL or LFA-1α, is a 170-180 kDa transmembrane glycoprotein that forms a heterodimer with CD18 (PMID: 7027264; 1672643). CD11a/CD18 (LFA-1) is expressed by all leukocytes and mediates cell adhesion through interactions with its ligands, intercellular adhesion molecule 1 (ICAM-1), ICAM-2, and ICAM-3 (PMID: 7479767). CD11a/CD18 also functions in lymphocyte costimulatory signaling (PMID: 1972160).
Protocols
Product Specific Protocols | |
---|---|
FC protocol for APC-Cyanine7 CD11a antibody AY7-65563 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |